IMPRIMIS PHARMACEUTICALS INC's ticker is IMMY and the CUSIP is 45323A201. A total of 30 filers reported holding IMPRIMIS PHARMACEUTICALS INC in Q3 2018. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2018 | $4,000 | +100.0% | 720 | -5.8% | 0.00% | – |
| Q3 2018 | $2,000 | 0.0% | 764 | +6.1% | 0.00% | – |
| Q2 2018 | $2,000 | +100.0% | 720 | 0.0% | 0.00% | – |
| Q1 2018 | $1,000 | 0.0% | 720 | 0.0% | 0.00% | – |
| Q4 2017 | $1,000 | 0.0% | 720 | 0.0% | 0.00% | – |
| Q3 2017 | $1,000 | -50.0% | 720 | -0.1% | 0.00% | – |
| Q2 2017 | $2,000 | – | 721 | +17925.0% | 0.00% | – |
| Q1 2017 | $0 | -100.0% | 4 | -100.0% | 0.00% | – |
| Q1 2016 | $61,000 | -42.5% | 15,316 | 0.0% | 0.00% | – |
| Q4 2015 | $106,000 | – | 15,316 | +84988.9% | 0.00% | – |
| Q4 2013 | $0 | – | 18 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Revelation Capital Management Ltd. | 272,671 | $1,227,000 | 1.45% |
| BARD ASSOCIATES INC | 64,100 | $288,000 | 0.13% |
| KENNEDY CAPITAL MANAGEMENT LLC | 240,587 | $1,083,000 | 0.02% |
| Trutina Financial LLC | 1,750 | $8,000 | 0.01% |
| REGIONS FINANCIAL CORP | 30,500 | $137,000 | 0.00% |
| Tower Research Capital LLC (TRC) | 848 | $4,000 | 0.00% |
| DEUTSCHE BANK AG\ | 294 | $1,000 | 0.00% |
| BlackRock Fund Advisors | 9,988 | $45,000 | 0.00% |
| VANGUARD GROUP INC | 63,100 | $298,000 | 0.00% |
| US BANCORP \DE\ | 5,099 | $23,000 | 0.00% |